Author + information
- Received November 16, 2017
- Revision received March 7, 2018
- Accepted March 9, 2018
- Published online May 14, 2018.
- aAlbert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York
- bJohn Ochsner Heart and Vascular Institute, Ochsner Clinical School, New Orleans, Louisiana
- cThe University of Queensland School of Medicine, St. Lucia, Queensland, Australia
- ↵∗Address for correspondence:
Dr. Ileana L. Piña, Department of Cardiology, Montefiore Medical Center, 1825 Eastchester Avenue, Second Floor, Cardiology, Bronx, New York 10467.
This review discusses common mental health disorders and their associations with cardiovascular disease risks. Commonly found mental health disorders include depression, anxiety, and personality types. The link between depression and cardiovascular disease mortality has been established. Depression is also common in patients with heart failure. In addition to discussing psychological disorders, a review of psychotropic drugs is also included. Drugs are described for therapy for depression and anxiety, as well as associations with cardiovascular drug-drug interactions. Drug-drug interactions are more common and potentially dangerous in elderly patients, in whom the conditions often coexist. The most common drug-drug interactions involve the P450 system of enzymes.
The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
- Received November 16, 2017.
- Revision received March 7, 2018.
- Accepted March 9, 2018.
- 2018 American College of Cardiology Foundation
This article requires a subscription or purchase to view the full text. If you are a subscriber or member, click Login or the Subscribe link (top menu above) to access this article.